VERTEX PHARMACEUTICALS INC / MA Derivative Liability, Noncurrent
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Derivative Liability, Noncurrent of $72.12 million as of 2010-09-30, per its 10-Q filed 2010-10-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2011-02-17
- 2010-09-30: Derivative Liability, Noncurrent $72.12M.
- 2010-06-30: Derivative Liability, Noncurrent $63.08M.
- 2010-03-31: Derivative Liability, Noncurrent $39.38M.
- 2009-12-31: Derivative Liability, Noncurrent $38.21M.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2010-09-30 | $72.12M 10-Q · filed 2010-10-28 |
| 2010-06-30 | $63.08M 10-Q · filed 2010-08-03 |
| 2010-03-31 | $39.38M 10-Q · filed 2010-05-03 |
| 2009-12-31 | $38.21M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |